v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Mar. 31, 2012
Apr. 02, 2011
Operating activities:    
Net earnings $ 14,075 $ 8,373
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 2,254 811
Deferred income tax expense 330 21
Gross excess tax benefit from exercise of stock options and vesting of restricted stock units (113) (127)
Stock-based compensation expense 1,028 974
Changes in:    
Accounts receivable, net (3,084) (786)
Inventory 8,502 (1,404)
Prepaid expenses and other assets 34 204
Accounts payable (6,856) (1,675)
Accrued expenses 6,113 (1,632)
Accrued retirement costs and other (590) (436)
Net cash provided by operating activities 21,693 4,323
Investing activities:    
Proceeds from the sale of short-term investments 22,287 16,802
Purchases of short-term investments (33,716) (9,866)
Acquisitions of principal assets of Foot Petals, LLC and baggallini, Inc. business operations, net of assumed liabilities   (47,702)
Purchases of property, plant and equipment (1,699) (643)
Net cash used in investing activities (13,128) (41,409)
Financing activities:    
Borrowings from revolving bank facility 3,000  
Payment of borrowings from revolving bank facility (3,000)  
Proceeds from long-term debt   30,000
Principal repayment of long-term debt (2,857) (429)
Proceeds from stock options exercised 704 77
Gross excess tax benefit from exercise of stock options and vesting of restricted stock units 113 127
Dividends paid (2,448) (2,319)
Net cash (used in) provided by financing activities (4,488) 27,456
Net increase (decrease) in cash and cash equivalents 4,077 (9,630)
Cash and cash equivalents at the beginning of the period 9,107 16,988
Cash and cash equivalents at the end of the period $ 13,184 $ 7,358